Synopsis:
The Board of Paushak Limited will meet on 11th August to consider a stock split, as well as a bonus issue of equity shares with a face value of Rs. 10 each.
During Thursday’s trading session, shares of India’s largest phosgene-based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries, surged around 3 percent on BSE, after a Board meeting is scheduled to consider a stock split and bonus shares.
With a market cap of Rs. 1,800.4 crores, the shares of Paushak Limited hit an intraday high at Rs. 6,050 on BSE, up by around 3.2 percent, as against its previous closing price of Rs. 5,860.05. The stock has delivered positive returns of over 2 percent in the last one year, and has gained by around 20 percent in the last one month.
What’s the News
According to the latest regulatory exchange filings, a meeting of the Board of Directors of Paushak Limited is scheduled to take place on Monday, 11th August 2025. During this meeting, the Board will discuss two key proposals aimed at enhancing shareholder value.
The first item on the agenda is the consideration of a sub-division or split of the company’s existing equity shares, which currently carry a face value of Rs. 10 each. The second proposal involves the issuance of bonus shares to eligible shareholders.
Financials & more
Paushak reported a marginal growth in its revenue from operations, showing a year-on-year increase of around 8 percent from Rs. 52 crores in Q1 FY25 to Rs. 56 crores in Q1 FY26. Likewise, its net profit increased during the same period from Rs. 10 crores to Rs. 12 crores, representing a significant growth of about 20 percent YoY.
Paushak Limited, an India-based company dealing in Speciality Chemicals Business, is engaged in the business of the production of phosgene gas and phosgene-based specialty chemicals/intermediates. Its products include isocyanates, chloroformates, carbamoyl chlorides, substituted urea, acid chlorides, carbonates, carbamates and others.
These chemicals are used in diverse fields, such as pesticides, pharmaceuticals, dyes, plastics and perfumeries. Paushak undertakes toll/contract manufacturing for phosgenation to produce carbamoyl chloride, isocyanate, choloformate and urea.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
